Abstract
Procainamide is a class la anti-arrhythmic used in a wide range of cardiac arrhythmias with properties similar to quinidine. The short duration of action and high incidence of side-effects generally limit its use to the acute control of arrhythmias where the less marked hypotensive action on intravenous administration relative to quinidine is an advantage. Grave hypotension and cardiac abnormalities are, however, major side-effects when procainamide is given too rapidly intravenously, and hypersensitivity reactions are an additional danger of long-term use. It is readily absorbed via the oral route, and acetylated in the liver to N-acetylprocainamide (acecainide) by enzymes which show a genetic polymorphism. There is therefore inter-subject variation in the production of N-acetylprocainamide which is an anti-arrhythmic in its own right and may represent a significant fraction of the drug in the circulation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer Science+Business Media New York
About this chapter
Cite this chapter
Wilson, J.F. (1995). Procainamide. In: Wilson, J.F. (eds) Drugs Eicosanoids. Immunoassay Kit Directory, vol 1 / 3 / 4. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-0679-5_43
Download citation
DOI: https://doi.org/10.1007/978-94-011-0679-5_43
Publisher Name: Springer, Dordrecht
Print ISBN: 978-0-7923-8863-0
Online ISBN: 978-94-011-0679-5
eBook Packages: Springer Book Archive